This is a preview of subscription content, log in via an institution to check access.
REFERENCE
Liu H, Michaud K, Nayak S, Karpf DB, Owens DK, Garber AM.The cost-effectiveness of therapy with teriparatide and alendronate in women with severe osteoporosis. Archives of Internal Medicine 166: 1209-1217, No. 11, 12 Jun 2006
Rights and permissions
About this article
Cite this article
Alendronic acid tops teriparatide in osteoporosis. Pharmacoecon. Outcomes News 510, 6 (2006). https://doi.org/10.2165/00151234-200605100-00015
Published:
Issue Date:
DOI: https://doi.org/10.2165/00151234-200605100-00015